99mTc sestamibi and 99mTc tetrofosmin scintigraphy for predicting resistance to chemotherapy: a critical review of clinical data.
Van de Wiele
C
C
Rottey
S
S
Goethals
I
I
Buscombe
J
J
Van Belle
S
S
De Vos
F
F
Dierckx
R A
RA
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy; D002277:Carcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy; D019008:Drug Resistance, Neoplasm; D004358:Drug Therapy / Q000379:methods; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D011379:Prognosis; D019275:Radiopharmaceuticals; D012509:Sarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals